Compared to Moderna and BioNTech, CureVac uses an older nucleotide chemistry, an older delivery technology, and a riskier adjuvanting idea. Both Moderna and Bio

Compared to Moderna and BioNTech, CureVac uses an older nucleotide chemistry, an older delivery technology, and a riskier adjuvanting idea. Both Moderna and BioNTech have GMP production capacity and process know-how to get this done in short-order. CureVac is a distant third place overall.